OncoMatch

OncoMatch/Clinical Trials/NCT06119867

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Is NCT06119867 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for colonic neoplasms.

Phase 3RecruitingRussian Society of Colorectal SurgeonsNCT06119867Data as of May 2026

In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.

Check if I qualify

Extracted eligibility criteria

Prior therapy

Must have received: colectomy

Patients diagnosed with colon cancer who underwent colectomy

Cannot have received: colectomy

Patients diagnosed with colon cancer but did not undergo colectomy

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify